Presently, Colin Bond is Non-Executive Chairman at European ScreeningPort GmbH and Chief Financial Officer of Vifor Pharma AG, Chief Financial Officer of Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG). Mr. Bond is also on the board of Siegfried Holding AG, Vifor Fresenius Medical Care Renal Pharma Ltd. and BioPharma Credit PLC and Member of Royal Pharmaceutical Society of Great Britain.

Mr. Bond previously was Chief Financial Officer of Evotec SE, Chief Financial Officer for Great Lakes Chemical Corp., Chief Financial Officer at Jet Aviation Management AG, Chief Financial Officer of Novelis AG, Chief Financial Officer of Novelis Europe Holdings Ltd., Chief Financial Officer at Ecolab (Schweiz) GmbH, Auditor at Procter & Gamble AG, Auditor of Arthur Andersen AG and Auditor at PricewaterhouseCoopers LLP.

He received an MBA from London Business School and an undergraduate degree from the University of Aston.